Please assess the completion status of the following clinical trial:

Trial Title: Enhanced Lung Protective Ventilation With ECCO2R During ARDS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* ARDS moderate or severe (Berlin criteria)~* Onset \< 48 h~* Driving pressure ≥ 11 cmH2O~Exclusion Criteria:~* Lack of consent or social protection~* Chronic respiratory failure (requiring Oxygen or NIPPV)~* Severe hypoxemia: PaO2/FIO2 \< 80 with PEEP ≥ 18 cmH2O AND FIO2= 1~* Acute Renal Failure requiring RRT~* DNR order or death expected within the next 72 hours~* Planned surgery or transport out-of-ICU expected within the next 72 hours~* Heparin allergy~* Contraindication to jugular vein catheterization~* Intracranial Hypertension

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Minimal distension (Type: EXPERIMENTAL): Tidal volume 4 ml/kg PBW and positive end-expiratory pressure (PEEP) based on the ARDSNet PEEP/FiO2 table (ARMA) + ECCO2R (sweep gas = 8 L/min, blood flow = 400 mL/min)
- Maximal recruitment (Type: EXPERIMENTAL): Tidal volume 4 ml/kg PBW and PEEP adjusted to maintain a plateau pressure between 23 - 25 cmH2O + ECCO2R (sweep gas = 8 L/min, blood flow = 400 mL/min)
- Standard (Type: ACTIVE_COMPARATOR): Tidal volume 6 ml/kg PBW and positive end-expiratory pressure (PEEP) based on the ARDSNet PEEP/FiO2 table (ARMA) without ECCO2R (no sweep gas flow, blood flow = 400 mL/min)

Based on this trial design, predict the completion outcome and termination type (if applicable).